Watch-and-wait approach remains 'reasonable' for some patients with follicular lymphoma - Healio

With new developments in the treatment of follicular lymphoma, such as chimeric antigen receptor T-cell therapies, whether the traditional watch-and-wait approach remains acceptable has been thrown into question.In an interview with Healio, Jean L. Koff, MD, …

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.Back to Healio With new developments in the treatment o… [+8051 chars]

full article...